These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9636596)

  • 21. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
    Freise CE; Hebert M; Osorio RW; Nikolai B; Lake JR; Kauffman RS; Ascher NL; Roberts JP
    Transplant Proc; 1993 Apr; 25(2):1758-9. PubMed ID: 8470155
    [No Abstract]   [Full Text] [Related]  

  • 22. [Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
    Alvarez Castro AM; Seijo Ríos S; Molina Pérez E; Castroagudín JF; Varo Pérez E
    Gastroenterol Hepatol; 2012 Nov; 35(9):649-51. PubMed ID: 22749511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.
    Fasola CG; Netto GJ; Jennings LW; Christensen LL; Molmenti EP; Sanchez EQ; Levy MF; Goldstein RM; Klintmalm GB
    Transplant Proc; 2002 Aug; 34(5):1563-4. PubMed ID: 12176486
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M; Neumann U; Knoop M; Bechstein WO; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract]   [Full Text] [Related]  

  • 25. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
    Eason JD; Nair S; Cohen AJ; Blazek JL; Loss GE
    Transplantation; 2003 Apr; 75(8):1396-9. PubMed ID: 12717237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
    Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction.
    Burke GW; Ciancio G; Alejandro R; Roth D; Ricordi C; Tzakis A; Miller J
    Transplant Proc; 1998 Jun; 30(4):1544-5. PubMed ID: 9636627
    [No Abstract]   [Full Text] [Related]  

  • 28. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
    Kliem V; Radermacher J; Hiss M; Pethig M; Burg M; Brunkhorst R
    Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone.
    Khauli RB; Medawar WA; Habbal AA; Birbari AE; Daouk MM; Abdelnoor AM; Uwaydah M; Rahman Bizri A; Sanjad S; Ayvazian PJ; Lovewell T; Stoff JS; Yang Fan P; Bigwood P; Harland R
    Transplant Proc; 2001 Aug; 33(5):2776-7. PubMed ID: 11498156
    [No Abstract]   [Full Text] [Related]  

  • 30. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
    Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
    Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.
    Nelson DR; Soldevila-Pico C; Reed A; Abdelmalek MF; Hemming AW; Van der Werf WJ; Howard R; Davis GL
    Liver Transpl; 2001 Dec; 7(12):1064-70. PubMed ID: 11753908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
    Tisone G; Laria G; Orlando G; Pisani F; Palmieri GP; Bellanova G; Torri E; Buonomo O; Angelico M; Casciani CU
    Transplant Proc; 1999 Dec; 31(8):3167-8. PubMed ID: 10616427
    [No Abstract]   [Full Text] [Related]  

  • 33. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 34. Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
    Ghobrial RM; Colquhoun S; Rosen H; Hollis P; Ponthieux S; Pakrasi A; Farmer DG; Markman JF; Markowitz J; Drazan K; Yersiz H; Singer J; Stribling R; Arnout W; Holt CD; Goss J; Imagawa D; Seu P; Goldstein LI; Shackleton CR; Martin P; Busuttil RW
    Transplant Proc; 1998 Jun; 30(4):1470-1. PubMed ID: 9636597
    [No Abstract]   [Full Text] [Related]  

  • 35. Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy.
    Kaufman DB; Leventhal JR; Stuart J; Parker M; Abecassis M; Fryer JP; Stuart FP
    Transplant Proc; 1999; 31(1-2):615-6. PubMed ID: 10083261
    [No Abstract]   [Full Text] [Related]  

  • 36. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
    Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 38. Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study.
    Fahlke J; Wolff S; Mantke R; Pross M; Weiss G; Buerger T; Lippert H
    Transplant Proc; 2002 Jun; 34(4):1242-4. PubMed ID: 12072328
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
    Langrehr JM; Lohmann R; Raakow R; Jonas S; Klupp J; Bechstein WO; Neuhaus R; Neuhaus P
    Transplant Proc; 2001 May; 33(3):2290-1. PubMed ID: 11377531
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycophenolate mofetil for prevention of acute rejection.
    Moore R; Griffin P; Darby C; Jurewicz A; Lord R
    Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.